Liver health check: how does nemtabrutinib behave?

NCT ID NCT06442436

First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 22 times

Summary

This study looks at how the drug nemtabrutinib is processed in the body of people with moderate liver impairment compared to healthy people. About 32 adults will take a single dose of the drug, and researchers will measure drug levels and safety. The goal is to understand if liver problems affect how the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT (HI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Pharmacology of Miami ( Site 0003)

    RECRUITING

    Miami, Florida, 33172, United States

    Contact Phone: •••-•••-••••

  • Orlando Clinical Research Center ( Site 0001)

    RECRUITING

    Orlando, Florida, 32809, United States

    Contact Phone: •••-•••-••••

  • Texas Liver Institute ( Site 0002)

    RECRUITING

    San Antonio, Texas, 78215, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.